首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1494859

到 2030 年更年期熱潮紅市場預測：按產品類型、治療類型、嚴重程度、應用、最終用戶和地區進行的全球分析

Menopausal Hot Flashes Market Forecasts to 2030 - Global Analysis By Product (Tablets, Patches, Creams & Gels, Injections and Other Products), Treatment Type, Severity, Application, End User and By Geography

出版日期: 2024年06月06日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，2024 年全球更年期熱潮紅市場規模為 172.7 億美元，預計 2030 年將達到 244.5 億美元，複合年成長率為 7.2%。

更年期熱潮紅是一種突然的、強烈的熱感，通常發生在 40 歲末至 50 歲出頭的女性身上，預示著向閉經的過渡。這些熱潮紅永續幾秒鐘到幾分鐘，並伴隨出汗、臉紅和心率加快。發生這種情況是因為荷爾蒙波動，尤其是雌激素水平低，會擾亂體溫調節。

根據2021年8月發表在《北美更年期協會雜誌》上的一篇論文，據觀察，美國更年期血管舒縮症狀的盛行率高達77%。

世界老化

隨著女性老齡化，她們更有可能出現熱潮紅（這是更年期的常見症狀），從而增加了對緩解這些症狀的治療和療法的需求。隨著越來越多的人進入更年期，旨在緩解熱潮紅和相關不適的藥物、荷爾蒙療法和替代療法的市場不斷成長。這些人口變化增強了人們對更年期健康的興趣，並加速了更年期熱潮紅市場的創新和研發投資。

安全問題

由於乳癌、血栓和中風等潛在風險，更年期熱潮紅市場的安全問題圍繞著荷爾蒙補充療法的使用。此外，人們也擔心草藥補充品等替代療法的有效性和安全性。這些安全問題影響了患者的信心，導致採用率降低，醫療保健提供者不願開出某些治療方法，阻礙了市場的成長。

現代生活方式

現代生活方式的特徵是壓力、不規律的睡眠模式和不健康的飲食習慣，導致女性荷爾蒙失衡，並加劇熱潮紅等更年期症狀。久坐的生活方式和環境因素的增加也起了一定的作用。製藥公司正在透過創新療法來滿足這些不斷成長的消費者需求。隨著女性尋求有效的解決方案來控制症狀和維持生活品質，針對更年期熱潮紅的產品市場正在迅速擴大。

增加替代療法的可用性

更年期熱潮紅的替代療法，如草藥補充品、針灸和生活方式改變，正變得越來越可用，這對傳統藥物治療的發展提出了挑戰。此外，一些替代療法的功效和安全性尚未得到充分研究或監管，這給患者和醫療保健提供者帶來了不確定性。這種轉變減少了對傳統藥物的需求並影響市場成長。

COVID-19 的影響

COVID-19 大流行透過擾亂醫療服務、延遲診斷和減少患者就診來影響更年期熱潮紅市場。供應鏈中斷正在影響藥物和治療的取得。經濟不確定性導致患者面臨經濟困難，影響他們接受治療的能力。然而，遠端醫療和虛擬諮詢的普及透過提供替代的醫療保健訪問選項部分緩解了這些挑戰。

荷爾蒙治療領域預計在預測期內將是最大的

荷爾蒙治療領域預計將出現良好的成長。更年期熱潮紅的荷爾蒙治療通常涉及荷爾蒙補充療法（HRT），即單獨使用雌激素或與黃體酮聯合使用。這些治療可以幫助調節荷爾蒙水平並緩解熱潮紅等症狀。 HRT 以錠劑、貼片、凝膠、乳霜等形式施用。儘管有效，但它可能帶來血栓、中風和乳癌等風險，因此通常建議在醫療監督下使用最短的必要時間。

預測期內荷爾蒙療法的女性族群預計複合年成長率最高

預計接受荷爾蒙療法的女性在預測期內的複合年成長率最高。接受荷爾蒙療法（HT）的女性更年期熱潮紅可以透過雌激素或雌激素和黃體激素的組合來有效控制。透過穩定荷爾蒙水平，HT 可以幫助減少熱潮紅的頻率和嚴重程度。然而，荷爾蒙療法有副作用，並不適合所有人。考慮進行 HT 的女性應與醫療保健提供者討論風險和益處，以確定針對其症狀的最佳選擇。

比最大的地區

預計亞太地區在預測期內將佔據最大的市場佔有率。人們對更年期健康意識的提高和人口老化的加劇，尤其是在日本和韓國等國家，正在推動市場擴張。採用西方生活方式，包括飲食改變和久坐習慣，導致更年期症狀的盛行率增加。然而，遠距遠端醫療的進步和醫療基礎設施的改善正在逐漸解決這些障礙並支持市場開拓。

複合年成長率最高的地區：

預計北美在預測期內的複合年成長率最高。該地區人口老化以及對更年期症狀和管理的認知不斷提高，對有效治療的需求不斷增加。儘管醫學技術進步提供了創新的解決方案，但荷爾蒙療法的安全問題仍然存在。北美市場仍然是一個重要的市場，有許多治療方案可以滿足更年期熱潮紅女性的需求。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

公司簡介
- 其他市場參與企業的綜合分析（最多 3 家公司）
- 主要企業SWOT分析（最多3家企業）
區域分割
- 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
競爭基準化分析
- 按產品系列、地理分佈和策略聯盟對主要企業基準化分析

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地區
中東/非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東/非洲

第11章主要進展

合約、夥伴關係、協作和合資企業
收購和合併
新產品發布
業務擴展
其他關鍵策略

第12章公司概況

Pfizer Inc.
Allergan PLC
Bayer AG
Novartis AG
GlaxoSmithKline PLC
Johnson & Johnson
Novo Nordisk A/S
Teva Pharmaceutical Industries Limited
Mylan NV
Amgen Inc.
Merck & Co Inc.
Perrigo Company
Astellas Pharma Inc.
TherapeuticsMD Inc.
Hisamitsu Pharmaceutical Corporation
Endo International PLC

簡介目錄圖表

Product Code: SMRC26379

According to Stratistics MRC, the Global Menopausal Hot Flashes Market is accounted for $17.27 billion in 2024 and is expected to reach $24.45 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Menopausal hot flashes are sudden, intense feelings of heat that typically affect women in their late 40s to early 50s, marking the transition into menopause. These flashes can last from a few seconds to several minutes, accompanied by sweating, flushing of the face, and a rapid heartbeat. They are caused by hormonal fluctuations, particularly a decline in estrogen levels, which disrupt the body's temperature regulation.

According to an article published in the Journal of the North American Menopause Society in August 2021, it has been observed that the prevalence of vasomotor menopausal symptoms was high in the United States with 77%.

Market Dynamics:

Driver:

Global aging population

As women age, they are more likely to experience hot flashes, a common symptom of menopause, driving the demand for treatments and therapies to alleviate these symptoms. With a larger demographic entering menopausal age brackets, there's an increased market for pharmaceuticals, hormone therapies, and alternative remedies aimed at alleviating hot flashes and related discomfort. This demographic shift amplifies the focus on menopausal health, spurring innovation and investment in research and development within the menopausal hot flashes market.

Restraint:

Safety concerns

Safety concerns in the menopausal hot flashes market primarily revolve around the use of hormone replacement therapies due to potential risks such as increased likelihood of breast cancer, blood clots, and stroke. Additionally, there are concerns regarding the efficacy and safety of alternative treatments such as herbal supplements. These safety concerns hinder market growth by impacting patient confidence, leading to decreased adoption rates and reluctance among healthcare providers to prescribe certain treatments.

Opportunity:

Mounting modern lifestyles

Mounting modern lifestyles, characterized by stress, erratic sleep patterns, and unhealthy dietary habits, contribute to hormonal imbalances in women, exacerbating menopausal symptoms like hot flashes. Increased prevalence of sedentary lifestyles and environmental factors also play a role. Pharmaceutical companies respond with innovative treatments and therapies to address this growing consumer need. As women seek effective solutions to manage their symptoms and maintain their quality of life, the market for products targeting menopausal hot flashes expands rapidly.

Threat:

Rising availability of alternative therapies

The increasing availability of alternative therapies for menopausal hot flashes, such as herbal supplements, acupuncture, and lifestyle changes, poses a challenge to the growth of traditional pharmaceutical treatments. Additionally, the efficacy and safety of some alternative therapies may not be thoroughly researched or regulated, leading to uncertainties among patients and healthcare providers. This shift reduces demand for conventional medications, impacting market growth.

Covid-19 Impact

The covid-19 pandemic has impacted the menopausal hot flashes market by disrupting healthcare services, delaying diagnosis, and reducing patient visits. Supply chain disruptions have affected the availability of medications and treatments. Economic uncertainties have led to financial constraints among patients, affecting their ability to afford treatments. However, increased telemedicine adoption and virtual consultations have partially mitigated these challenges by providing alternative healthcare access options.

The hormonal treatment segment is expected to be the largest during the forecast period

The hormonal treatment segment is estimated to have a lucrative growth. Hormonal treatments for menopausal hot flashes often involve hormone replacement therapy (HRT), which includes estrogen alone or combined with progesterone. These treatments help regulate hormone levels, alleviating symptoms like hot flashes. HRT can be administered through pills, patches, gels, or creams. It's effective but may carry risks such as blood clots, stroke, or breast cancer, so it's usually recommended for the shortest duration necessary and under medical supervision.

The women on hormone therapy segment is expected to have the highest CAGR during the forecast period

The women on hormone therapy segment is anticipated to witness the highest CAGR growth during the forecast period. Menopausal hot flashes in women on hormone therapy (HT) can be effectively managed with estrogen or a combination of estrogen and progestin. HT helps reduce the frequency and severity of hot flashes by stabilizing hormone levels. However, it may have side effects and is not suitable for everyone. Women considering HT should discuss risks and benefits with their healthcare provider to determine the best course of action for their symptoms.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. Increasing awareness about menopausal health, coupled with a rising aging population, particularly in countries like Japan and South Korea, is driving market expansion. The adoption of Western lifestyles, including dietary changes and sedentary habits, is contributing to a higher prevalence of menopausal symptoms. Nevertheless, advancements in telemedicine and increasing healthcare infrastructure are gradually addressing these barriers, fostering market development.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. The region's aging population, combined with a high level of awareness about menopausal symptoms and their management, drives demand for effective treatments. Technological advancements in pharmaceuticals offer innovative solutions, although safety concerns regarding hormone therapy persist. The market in North America remains significant, with a range of treatment options available to cater to the needs of women experiencing menopausal hot flashes.

Key players in the market

Some of the key players profiled in the Menopausal Hot Flashes Market include Pfizer Inc., Allergan PLC, Bayer AG, Novartis AG, GlaxoSmithKline PLC, Johnson & Johnson, Novo Nordisk A/S, Teva Pharmaceutical Industries Limited, Mylan N.V., Amgen Inc., Merck & Co Inc., Perrigo Company, Astellas Pharma Inc., TherapeuticsMD Inc., Hisamitsu Pharmaceutical Corporation and Endo International PLC.

Key Developments:

In May 2023, Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has approved VEOZAHTM (fezolinetant) 45 mg once daily for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause1. VEOZAH is the first nonhormonal neurokinin 3 (NK3) receptor antagonist approved to treat VMS due to menopause.

Products Covered:

Tablets
Patches
Creams & Gels
Injections
Other Products

Treatment Types Covered:

Hormonal Treatment
Non-Hormonal Treatment
Over-the-Counter (OTC) Products
Alternative Therapies

Severities Covered:

Mild
Moderate
Severe

Applications Covered:

Perimenopausal & Postmenopausal Women
Breast Cancer Patients
Women on Hormone Therapy
Other Applications

End Users Covered:

Hospitals
Homecare
Specialty Clinics
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Menopausal Hot Flashes Market, By Product

5.1 Introduction
5.2 Tablets
5.3 Patches
5.4 Creams & Gels
5.5 Injections
5.6 Other Products

6 Global Menopausal Hot Flashes Market, By Treatment Type

6.1 Introduction
6.2 Hormonal Treatment
- 6.2.1 Estrogen Replacement Therapy
- 6.2.2 Progesterone Replacement Therapy
- 6.2.3 Combination Therapy
6.3 Non-Hormonal Treatment
- 6.3.1 Antidepressants
- 6.3.2 Anticonvulsants
- 6.3.3 Antihypertensives
6.4 Over-the-Counter (OTC) Products
- 6.4.1 Herbal Supplements
- 6.4.2 Vitamins & Minerals
- 6.4.3 Phytoestrogens
6.5 Alternative Therapies
- 6.5.1 Acupuncture
- 6.5.2 Yoga & Exercise Programs
- 6.5.3 Behavioral Therapies

7 Global Menopausal Hot Flashes Market, By Severity

7.1 Introduction
7.2 Mild
7.3 Moderate
7.4 Severe

8 Global Menopausal Hot Flashes Market, By Application

8.1 Introduction
8.2 Perimenopausal & Postmenopausal Women
8.3 Breast Cancer Patients
8.4 Women on Hormone Therapy
8.5 Other Applications

9 Global Menopausal Hot Flashes Market, By End User

9.1 Introduction
9.2 Hospitals
9.3 Homecare
9.4 Specialty Clinics
9.5 Other End Users

10 Global Menopausal Hot Flashes Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Pfizer Inc.
12.2 Allergan PLC
12.3 Bayer AG
12.4 Novartis AG
12.5 GlaxoSmithKline PLC
12.6 Johnson & Johnson
12.7 Novo Nordisk A/S
12.8 Teva Pharmaceutical Industries Limited
12.9 Mylan N.V.
12.10 Amgen Inc.
12.11 Merck & Co Inc.
12.12 Perrigo Company
12.13 Astellas Pharma Inc.
12.14 TherapeuticsMD Inc.
12.15 Hisamitsu Pharmaceutical Corporation
12.16 Endo International PLC

簡介目錄圖表

List of Tables

Table 1 Global Menopausal Hot Flashes Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Menopausal Hot Flashes Market Outlook, By Product (2022-2030) ($MN)
Table 3 Global Menopausal Hot Flashes Market Outlook, By Tablets (2022-2030) ($MN)
Table 4 Global Menopausal Hot Flashes Market Outlook, By Patches (2022-2030) ($MN)
Table 5 Global Menopausal Hot Flashes Market Outlook, By Creams & Gels (2022-2030) ($MN)
Table 6 Global Menopausal Hot Flashes Market Outlook, By Injections (2022-2030) ($MN)
Table 7 Global Menopausal Hot Flashes Market Outlook, By Other Products (2022-2030) ($MN)
Table 8 Global Menopausal Hot Flashes Market Outlook, By Treatment Type (2022-2030) ($MN)
Table 9 Global Menopausal Hot Flashes Market Outlook, By Hormonal Treatment (2022-2030) ($MN)
Table 10 Global Menopausal Hot Flashes Market Outlook, By Estrogen Replacement Therapy (2022-2030) ($MN)
Table 11 Global Menopausal Hot Flashes Market Outlook, By Progesterone Replacement Therapy (2022-2030) ($MN)
Table 12 Global Menopausal Hot Flashes Market Outlook, By Combination Therapy (2022-2030) ($MN)
Table 13 Global Menopausal Hot Flashes Market Outlook, By Non-Hormonal Treatment (2022-2030) ($MN)
Table 14 Global Menopausal Hot Flashes Market Outlook, By Antidepressants (2022-2030) ($MN)
Table 15 Global Menopausal Hot Flashes Market Outlook, By Anticonvulsants (2022-2030) ($MN)
Table 16 Global Menopausal Hot Flashes Market Outlook, By Antihypertensives (2022-2030) ($MN)
Table 17 Global Menopausal Hot Flashes Market Outlook, By Over-the-Counter (OTC) Products (2022-2030) ($MN)
Table 18 Global Menopausal Hot Flashes Market Outlook, By Herbal Supplements (2022-2030) ($MN)
Table 19 Global Menopausal Hot Flashes Market Outlook, By Vitamins & Minerals (2022-2030) ($MN)
Table 20 Global Menopausal Hot Flashes Market Outlook, By Phytoestrogens (2022-2030) ($MN)
Table 21 Global Menopausal Hot Flashes Market Outlook, By Alternative Therapies (2022-2030) ($MN)
Table 22 Global Menopausal Hot Flashes Market Outlook, By Acupuncture (2022-2030) ($MN)
Table 23 Global Menopausal Hot Flashes Market Outlook, By Yoga & Exercise Programs (2022-2030) ($MN)
Table 24 Global Menopausal Hot Flashes Market Outlook, By Behavioral Therapies (2022-2030) ($MN)
Table 25 Global Menopausal Hot Flashes Market Outlook, By Mild (2022-2030) ($MN)
Table 26 Global Menopausal Hot Flashes Market Outlook, By Moderate (2022-2030) ($MN)
Table 27 Global Menopausal Hot Flashes Market Outlook, By Severe (2022-2030) ($MN)
Table 28 Global Menopausal Hot Flashes Market Outlook, By Application (2022-2030) ($MN)
Table 29 Global Menopausal Hot Flashes Market Outlook, By Perimenopausal & Postmenopausal Women (2022-2030) ($MN)
Table 30 Global Menopausal Hot Flashes Market Outlook, By Breast Cancer Patients (2022-2030) ($MN)
Table 31 Global Menopausal Hot Flashes Market Outlook, By Women on Hormone Therapy (2022-2030) ($MN)
Table 32 Global Menopausal Hot Flashes Market Outlook, By Other Applications (2022-2030) ($MN)
Table 33 Global Menopausal Hot Flashes Market Outlook, By End User (2022-2030) ($MN)
Table 34 Global Menopausal Hot Flashes Market Outlook, By Hospitals (2022-2030) ($MN)
Table 35 Global Menopausal Hot Flashes Market Outlook, By Homecare (2022-2030) ($MN)
Table 36 Global Menopausal Hot Flashes Market Outlook, By Specialty Clinics (2022-2030) ($MN)
Table 37 Global Menopausal Hot Flashes Market Outlook, By Other End Users (2022-2030) ($MN)